Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

The quest to understand and slow disease progression in multiple sclerosis (MS) continued in 2024, with research revealing ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

The goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. Though several new medications have been approved in recent years that are effective ...

for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing medicine. The commission said the pharmaceutical ...

Once your computers have the program installed and running, you’ll need to get them talking to each other. On the server machine, click the Configure Server button. In the upper left-hand corner ...

Leptomeningeal inflammation in a mouse model of multiple sclerosis triggers deeply penetrating gene changes in underlying brain tissue, described using spatial transcriptomics.

Brain inflammation is a hallmark of multiple sclerosis. Using novel spatial transcriptomics methods, the authors provide solid evidence for a gradient of immune genes and inflammatory markers from the ...

Theoretically, this could make it useful for treating multiple sclerosis (MS), in which inflammation from the immune system damages nerves. However, curcumin has poor bioavailability, meaning the body ...